BOSTON — A federal grand jury in Boston has been seated to investigate the Framingham compounding pharmacy that manufactured tainted steroid injections blamed for at least 36 deaths.
BOSTON — The call for JudyAnn Bigby’s resignation follows the state drug lab scandal and the meningitis outbreak.
WASHINGTON — The group wants the FDA to revisit 16 compounding pharmacies that received warning letters from the agency between 2003 and 2012.
BOSTON — Physicians and pharmacists at MGH are hopeful the hospital’s drug management and compounding effort will lead to improved prescribing practices.
BOSTON — A federal judge is restricting some of the assets of the New England Compounding Center, but has rejected a request to freeze them completely.
NASHVILLE, Tenn. — Tennessee health officials will contact hundreds of people who received steroid injections for back pain from a pharmacy linked to a fungal meningitis outbreak.
BOSTON — State public health regulators have approved a new rule allowing hospitals to share compounded medications in the event of future drug shortages.
BOSTON — Lawyers for the NECC argued freezing assets would be a radical move so early after the suits were filed.
BOSTON — Mass. Attorney General Martha Coakley says the deadly meningitis outbreak linked to a Framingham company illustrates why a nearly 200-year-old corporate manslaughter statute should be updated.
BOSTON — We speak with Connecticut’s senator, following a second day of congressional hearings on the nationwide outbreak.